MAIA Biotechnology Shines at ASCO 2025 with Poster Presentation
MAIA Biotechnology, Inc. has gained recognition at the prestigious ASCO 2025 Annual Meeting, highlighting its commitment to advancing cancer treatment through innovative drug development.
2 minutes to read